This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
Ocular Therapeutix, Inc.
Q12026
5/5/2026
Operator
Conference Operator
Thank you for your continued patience. Your meeting will begin shortly.
Operator
Conference Operator
If you need assistance at any time, please press star zero and a member of our team will be happy to help you. ¶¶ Thank you. © transcript Emily Beynon © transcript Emily Beynon ¶¶ ¶¶ ¶¶
Operator
Conference Operator
Good morning and welcome to the Ocular Therapeutics first quarter 2026 earnings conference call. At this time, all participants are in a listen-only mode. After the prepared remarks, we will conduct a question and answer session. If you would like to ask a question, please press star 1 on your telephone. As a reminder, this conference call is being recorded and will be available for replay on the investor relations section of the Ocular Therapeutics website. I would now like to turn the call over to Ocular's Vice President of Investor Relations, Bill Slattery, Jr. Please go ahead, Mr. Slattery.
You're reading a preview of the OCUL Q1 2026 earnings call.
Free account.
Disclaimer